Pharma – Somerset Indus Capital Partners

Somerset Invests in Printmann Offset; Marks full deployment of Fund II

somerse_wp-capital — Tue, 20 Feb 2024 05:54:55 +0000

Somerset Indus is delighted to announce its investment in Printmann Group, further solidifying our commitment to fostering growth and innovation within the Pharma and Healthcare space, and marking the full deployment of our Fund II.

The Company is a pioneer in the manufacturing of paper-based packaging products such as cartons, leaflets, labels and foils. The funds would be deployed to accelerate growth, by pursuing both organic and inorganic growth initiatives.

India wants to be the ‘pharmacy of the world.’ But first, it must wean itself from China

somerse_wp-capital — Fri, 27 May 2022 07:08:28 +0000

“We will probably do better with low volume, by focusing on niche APIs than with high volume ones,” he said, adding that a lot of other chemical processes in the manufacturing cycle would also have to be moved to India to cut costs in the long run.

Globela Pharma – A Somerset Portfolio Company

somerse_wp-capital — Tue, 16 Nov 2021 13:46:28 +0000

A pharmaceutical formulations and API manufacturing company. Established in 2006, Globela is an established ISO, FDCA – India and WHO cGMP accredited formulations manufacturing company with multiple therapeutic areas including oncology, anti-infectives, gastro, CVS, etc. and sales presence across 30+ countries. It is an experienced manufacturer for high quality semi-finished, finished dosages formulation and active pharmaceutical ingredient products. It has an in-house fully equipped R&D center accredited by DSIR (Department of Scientific and Industrial Research). The company majorly caters to the needs of the Rest of the World (ROW) market, India, Africa, Asia, Latin America and Middle East and is expanding to regulated markets. The company has received UBM India Pharma Exporter of the Year Award- 2015 & 2017. The company is also a certified Star Export House by the DGFT and is classified as a preferred exporter by D&B (Dun and Bradstreet).

Somerset invests in Gujarat-based bulk drug firm in first pharma bet

somerse_wp-capital — Wed, 06 Oct 2021 15:27:10 +0000

Somerset Indus Capital Partners has picked up a minority stake in Gujarat-based Globela Pharma Pvt Ltd, marking the healthcare-focused private equity firm's first bet in the pharmaceutical space in India.